Hyperbaric Oxygen Therapy for COVID-19


  • Opelousas General Hospital in Louisiana has deployed “off-label compassionate use” of hyperbaric oxygen therapy (HBOT) for all COVID-19 patients with oxygen-resistant hypoxemia
  • During HBOT, you’re breathing air or oxygen in a pressurized chamber, which allows your body to bypass your lungs and directly absorb oxygen into your tissues. There’s no airflow being forced directly into the lungs, thus avoiding lung damage associated with ventilation
  • HBOT helps treat COVID-19 by reversing hypoxia, reducing inflammation in the lungs, increasing viricidal reactive oxygen species, upregulating HIF-increasing host defense peptides and reducing proinflammatory cytokines such as IL-6
  • Chinese doctors report “promising results” after treating five COVID-19 patients with HBOT. Two were in critical condition and five were severe. Patients experienced rapid relief of hypoxic symptoms, rapid correction of hypoxemia, improved lung pathology and a general reversal of associated conditions, including gastrointestinal symptoms
  • NYU Langone Health is recruiting 40 COVID-19 patients for a study using HBOT

Continue reading